NT_1170x120_1-11-18

Sawai Pharmaceutical

Upsher-Smith parent sells stake in U.S. generics unit

Upsher-Smith parent sells stake in U.S. generics unit

MAPLE GROVE, Minn. — Upsher-Smith Laboratories LLC said its Japan-based parent, Sawai Pharmaceutical Co., has agreed to sell a 20% stake in its Sawai America Inc. subsidiary to Sumitomo Corp. of Americas (SCOA). Under the deal, SCOA — part of global conglomerate Sumitomo Corp. — is slated to buy the interest in Sawai America for $211

Sawai wraps up acquisition of Upsher-Smith generics unit

Sawai wraps up acquisition of Upsher-Smith generics unit

TOKYO and MINNEAPOLIS — Sawai Pharmaceutical Co. Ltd. has closed its $1.05 billion acquisition of the Upsher-Smith Laboratories generic drug business. Sawai, which unveiled the deal with Upsher-Smith parent Acova Inc. in April, plans to retain Upsher’s headquarters in Minnesota and operation in Colorado. And as previously announced, Upsher-Smith will retain its current leadership, with